Tolerance of the small bowel to therapeutic irradiation

A focus on late toxicity in patients receiving para-aortic nodal irradiation for gynecologic malignancies

Sinisa Stanic, Jyoti S. Mayadev

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: The recently published Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) recommends dose constraints for acute small-bowel toxicity but does not fully address dose constraints for late small-bowel toxicity and the maximum dose tolerance of the small bowel. Radiation oncologists in practice frequently face a challenge when deciding what maximum point dose to accept in a patient's treatment plan. Given this lack of guidance for maximum radiation dose tolerance on the small bowel, we performed a literature search on the topic. Methods: We searched PubMed for English language publications up to December 2012 on pelvic and para-aortic lymph node (PALN) irradiation for gynecologic malignancies. The search was performed using the following key words: late small-bowel toxicity, cervical cancer, endometrial cancer, ovarian cancer, gynecologic malignancies, pelvic irradiation, PALN irradiation, extended-field radiation therapy. Relevant references were selected, and full articles were obtained for review. The predetermined criteria for deciding which studies to include were used. Results: With photon irradiation, the incidence of grade 3 or greater late small-bowel toxicity, including small-bowel obstruction, is 9% ± 7% after a median follow-up of 5 years and with mean pelvic and para-aortic/whole abdominal prescription doses of 50 ± 5 Gy and 40 ± 10 Gy, respectively. Our estimate for the small-bowel T10/5 would be the maximum point dose of 55 Gy. Conclusions: If possible, it is prudent to try to keep the maximum point dose to the small bowel at 55 Gy or less. Given the lack of substantial data to make firm guidelines, further studies are needed to clarify the dose-volume relationship for late toxicity. Dose escalation to PALN should continue to be used with caution.

Original languageEnglish (US)
Pages (from-to)592-597
Number of pages6
JournalInternational Journal of Gynecological Cancer
Volume23
Issue number4
DOIs
StatePublished - May 2013

Fingerprint

Lymph Nodes
Neoplasms
Radiation Tolerance
Endometrial Neoplasms
Photons
PubMed
Uterine Cervical Neoplasms
Ovarian Neoplasms
Prescriptions
Publications
Language
Radiotherapy
Therapeutics
Guidelines
Incidence
Radiation Oncologists

Keywords

  • Late toxicity
  • Maximum dose
  • Para-aortic nodal irradiation
  • Pelvic radiotherapy
  • Small bowel

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

@article{f761754704df42dfb7f39762101ad607,
title = "Tolerance of the small bowel to therapeutic irradiation: A focus on late toxicity in patients receiving para-aortic nodal irradiation for gynecologic malignancies",
abstract = "Objective: The recently published Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) recommends dose constraints for acute small-bowel toxicity but does not fully address dose constraints for late small-bowel toxicity and the maximum dose tolerance of the small bowel. Radiation oncologists in practice frequently face a challenge when deciding what maximum point dose to accept in a patient's treatment plan. Given this lack of guidance for maximum radiation dose tolerance on the small bowel, we performed a literature search on the topic. Methods: We searched PubMed for English language publications up to December 2012 on pelvic and para-aortic lymph node (PALN) irradiation for gynecologic malignancies. The search was performed using the following key words: late small-bowel toxicity, cervical cancer, endometrial cancer, ovarian cancer, gynecologic malignancies, pelvic irradiation, PALN irradiation, extended-field radiation therapy. Relevant references were selected, and full articles were obtained for review. The predetermined criteria for deciding which studies to include were used. Results: With photon irradiation, the incidence of grade 3 or greater late small-bowel toxicity, including small-bowel obstruction, is 9{\%} ± 7{\%} after a median follow-up of 5 years and with mean pelvic and para-aortic/whole abdominal prescription doses of 50 ± 5 Gy and 40 ± 10 Gy, respectively. Our estimate for the small-bowel T10/5 would be the maximum point dose of 55 Gy. Conclusions: If possible, it is prudent to try to keep the maximum point dose to the small bowel at 55 Gy or less. Given the lack of substantial data to make firm guidelines, further studies are needed to clarify the dose-volume relationship for late toxicity. Dose escalation to PALN should continue to be used with caution.",
keywords = "Late toxicity, Maximum dose, Para-aortic nodal irradiation, Pelvic radiotherapy, Small bowel",
author = "Sinisa Stanic and Mayadev, {Jyoti S.}",
year = "2013",
month = "5",
doi = "10.1097/IGC.0b013e318286aa68",
language = "English (US)",
volume = "23",
pages = "592--597",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Tolerance of the small bowel to therapeutic irradiation

T2 - A focus on late toxicity in patients receiving para-aortic nodal irradiation for gynecologic malignancies

AU - Stanic, Sinisa

AU - Mayadev, Jyoti S.

PY - 2013/5

Y1 - 2013/5

N2 - Objective: The recently published Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) recommends dose constraints for acute small-bowel toxicity but does not fully address dose constraints for late small-bowel toxicity and the maximum dose tolerance of the small bowel. Radiation oncologists in practice frequently face a challenge when deciding what maximum point dose to accept in a patient's treatment plan. Given this lack of guidance for maximum radiation dose tolerance on the small bowel, we performed a literature search on the topic. Methods: We searched PubMed for English language publications up to December 2012 on pelvic and para-aortic lymph node (PALN) irradiation for gynecologic malignancies. The search was performed using the following key words: late small-bowel toxicity, cervical cancer, endometrial cancer, ovarian cancer, gynecologic malignancies, pelvic irradiation, PALN irradiation, extended-field radiation therapy. Relevant references were selected, and full articles were obtained for review. The predetermined criteria for deciding which studies to include were used. Results: With photon irradiation, the incidence of grade 3 or greater late small-bowel toxicity, including small-bowel obstruction, is 9% ± 7% after a median follow-up of 5 years and with mean pelvic and para-aortic/whole abdominal prescription doses of 50 ± 5 Gy and 40 ± 10 Gy, respectively. Our estimate for the small-bowel T10/5 would be the maximum point dose of 55 Gy. Conclusions: If possible, it is prudent to try to keep the maximum point dose to the small bowel at 55 Gy or less. Given the lack of substantial data to make firm guidelines, further studies are needed to clarify the dose-volume relationship for late toxicity. Dose escalation to PALN should continue to be used with caution.

AB - Objective: The recently published Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) recommends dose constraints for acute small-bowel toxicity but does not fully address dose constraints for late small-bowel toxicity and the maximum dose tolerance of the small bowel. Radiation oncologists in practice frequently face a challenge when deciding what maximum point dose to accept in a patient's treatment plan. Given this lack of guidance for maximum radiation dose tolerance on the small bowel, we performed a literature search on the topic. Methods: We searched PubMed for English language publications up to December 2012 on pelvic and para-aortic lymph node (PALN) irradiation for gynecologic malignancies. The search was performed using the following key words: late small-bowel toxicity, cervical cancer, endometrial cancer, ovarian cancer, gynecologic malignancies, pelvic irradiation, PALN irradiation, extended-field radiation therapy. Relevant references were selected, and full articles were obtained for review. The predetermined criteria for deciding which studies to include were used. Results: With photon irradiation, the incidence of grade 3 or greater late small-bowel toxicity, including small-bowel obstruction, is 9% ± 7% after a median follow-up of 5 years and with mean pelvic and para-aortic/whole abdominal prescription doses of 50 ± 5 Gy and 40 ± 10 Gy, respectively. Our estimate for the small-bowel T10/5 would be the maximum point dose of 55 Gy. Conclusions: If possible, it is prudent to try to keep the maximum point dose to the small bowel at 55 Gy or less. Given the lack of substantial data to make firm guidelines, further studies are needed to clarify the dose-volume relationship for late toxicity. Dose escalation to PALN should continue to be used with caution.

KW - Late toxicity

KW - Maximum dose

KW - Para-aortic nodal irradiation

KW - Pelvic radiotherapy

KW - Small bowel

UR - http://www.scopus.com/inward/record.url?scp=84879984660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879984660&partnerID=8YFLogxK

U2 - 10.1097/IGC.0b013e318286aa68

DO - 10.1097/IGC.0b013e318286aa68

M3 - Article

VL - 23

SP - 592

EP - 597

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 4

ER -